IMPL
Price:
$0.04
Market Cap:
$956.00K
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa, which has completed Phase IIa clinical trial for the treatment of OFF episodes in Parkinson's disease. Impel Pharmaceuticals Inc. was f...[Read more]
Industry
Biotechnology
IPO Date
2021-04-23
Stock Exchange
NASDAQ
Ticker
IMPL
According to Impel Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -97.48% compared to the average of -0.51 of the last 4 quarters.
The mean historical PE Ratio of Impel Pharmaceuticals Inc. over the last ten years is -2.83. The current -0.01 PE Ratio has changed -54.77% with respect to the historical average. Over the past ten years (40 quarters), IMPL's PE Ratio was at its highest in in the September 2023 quarter at -0.18. The PE Ratio was at its lowest in in the March 2021 quarter at -6.45.
Average
-2.83
Median
-2.97
Minimum
-4.71
Maximum
-0.68
Discovering the peaks and valleys of Impel Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.68
Minimum Annual Increase = -61.74%
Minimum Annual PE Ratio = -4.71
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.68 | -58.74% |
| 2021 | -1.65 | -61.74% |
| 2020 | -4.30 | -8.60% |
The current PE Ratio of Impel Pharmaceuticals Inc. (IMPL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.21
5-year avg
-2.83
10-year avg
-2.83
Impel Pharmaceuticals Inc.’s PE Ratio is greater than InVivo Therapeutics Holdings Corporation (-0.05), less than 9 Meters Biopharma, Inc. (0), less than Infinity Pharmaceuticals, Inc. (-0.00), greater than Accelerate Diagnostics, Inc. (-0.02), greater than Bellicum Pharmaceuticals, Inc. (-0.09), greater than Altamira Therapeutics Ltd. (-0.02), greater than Timber Pharmaceuticals, Inc. (-0.04), greater than CohBar, Inc. (-0.10), less than Neptune Wellness Solutions Inc. (-0.00), less than Acorda Therapeutics, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.05 | $995.92K | |
| 0 | $1.45K | |
| -0.00 | $9.05K | |
| -0.02 | $859.92K | |
| -0.09 | $778.33K | |
| -0.02 | $1.13M | |
| -0.04 | $1.18M | |
| -0.10 | $1.19M | |
| -0.00 | $45.31K | |
| -0.00 | $821.03K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Impel Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Impel Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Impel Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Impel Pharmaceuticals Inc. (IMPL)?
What is the highest PE Ratio for Impel Pharmaceuticals Inc. (IMPL)?
What is the 3-year average PE Ratio for Impel Pharmaceuticals Inc. (IMPL)?
What is the 5-year average PE Ratio for Impel Pharmaceuticals Inc. (IMPL)?
How does the current PE Ratio for Impel Pharmaceuticals Inc. (IMPL) compare to its historical average?